Forward Citations = 319
Company Filing History:





Other
4. 20 out of 20
Emmanuelle Charpentier
where one patent can have more than one assignee
Emmanuelle Charpentier, born on December 11, 1968, is a French microbiologist and geneticist. Her groundbreaking work alongside biochemist Jennifer Doudna led to the discovery of the CRISPR-Cas9 gene-editing system. This revolutionary technology allows precise and efficient editing of DNA sequences, impacting fields from medicine to agriculture. In 2020, Charpentier and Doudna were jointly awarded the Nobel Prize in Chemistry for their pioneering contributions. She holds over 50 U.S. patents and co-founded CRISPR Therapeutics to advance this transformative genome engineering technology.
Get your Inventor Badge Today